𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study

✍ Scribed by Compta, Yaroslau; Pereira, Joana B.; Ríos, Jose; Ibarretxe-Bilbao, Naroa; Junqué, Carme; Bargalló, Núria; Cámara, Ana; Buongiorno, Mariateresa; Fernández, Manel; Pont-Sunyer, Claustre; Martí, Maria J.

Book ID
120284210
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
487 KB
Volume
19
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Associations between family history of P
Associations between family history of Parkinson's disease and dementia and risk of dementia in Parkinson's disease: A community-based, longitudinal study
✍ Martin Wilhelm Kurz; Jan Petter Larsen; Jan Terje Kvaloy; Dag Aarsland 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 1 views

## Abstract Dementia is common in patients with Parkinson's disease (PDD). The etiology of PDD is still unclear, but exciting advances have been made in discovering pathogenetic components in Parkinson's disease (PD), implicating the role of genetic factors. It is, however, still controversial whet

Neuropathology of dementia in Parkinson'
Neuropathology of dementia in Parkinson's disease: A prospective, community-based study
✍ Dag Aarsland; Robert Perry; Andrew Brown; Jan P. Larsen; Clive Ballard 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 3 views

## Abstract Twenty‐two patients with Parkinson's disease drawn from a community‐based study were followed prospectively until their deaths. Even though 18 patients had dementia, none fulfilled Braak and Braak or The National Institute on Aging and Ronald and Nancy Reagan Institute of the Alzheimer'

A longitudinal program for biomarker dev
A longitudinal program for biomarker development in Parkinson's disease: A feasibility study
✍ Bernard Ravina; Caroline Tanner; Diane DiEuliis; Shirley Eberly; Emily Flagg; We 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

## Abstract Long‐term follow up is necessary to understand the natural history of treated Parkinson's disease (PD). The Longitudinal and Biomarker Study in PD (LABS‐PD) is an observational study designed to prospectively measure the evolution of motor and non‐motor features of PD and sample promisi